Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC)
United Kingdom (UK)
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
19 | 0.49 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 17 | 0.44 | |
Physical Sciences | 2 | 0.05 | |
Chemistry | 1 | 0.01 |
Top articles by Altmetric score in current window
Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site
Science Translational Medicine
2020-01-22
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 50.83% Domestic
- 49.17% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (90 total)
- Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
- Domestic institution
-
University of Leeds, United Kingdom (UK)
(4.11)
-
St James's University Hospital, United Kingdom (UK)
(1.31)
-
Leeds Teaching Hospitals NHS Trust (LTHT), United Kingdom (UK)
(0.90)
-
The University of Manchester (UoM), United Kingdom (UK)
(0.67)
-
Genomics England Ltd., United Kingdom (UK)
(0.65)
-
Newcastle University, United Kingdom (UK)
(0.60)
-
Heriot-Watt University, United Kingdom (UK)
(0.40)
-
University of Glasgow, United Kingdom (UK)
(0.38)
-
University of Oxford, United Kingdom (UK)
(0.25)
-
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK)
(0.24)
Top 10 international collaborators by Share (546 total)
- Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
- Foreign institution
-
Agency for Science, Technology and Research (A*STAR), Singapore
(0.74)
-
National University of Singapore (NUS), Singapore
(0.55)
-
Duke-National University of Singapore (Duke-NUS), Singapore
(0.44)
-
National Institutes of Health (NIH), United States of America (USA)
(0.33)
-
Catholic University of Leuven (KU Leuven), Belgium
(0.28)
-
University of Rome Tor Vergata, Italy
(0.28)
-
Harvard University, United States of America (USA)
(0.26)
-
Duke University, United States of America (USA)
(0.24)
-
Helmholtz Association of German Research Centres, Germany
(0.23)
-
National University Health System (NUHS), Singapore
(0.19)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Experimental Cancer Medicine Centre (ECMC) Network, United Kingdom (UK)
- Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK)
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.